The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Automatic Transdermal System Market Research Report 2025
Synopsis
The automatic transdermal system is to test the decomposition and diffusion of transdermal drugs or cosmetics under controlled conditions under specified environment and conditions, so as to simulate the in vivo absorption process of the test substance.
Global Automatic Transdermal System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Automatic Transdermal System market research.
Compared with traditional medication methods, the advantages of transdermal drug delivery systems are the main reason for the rapid development of the market. In addition to effectively avoiding the first-pass effect of the liver, transdermal administration can reduce the irritation of the stomach and intestines caused by oral drugs and reduce the loss of drug efficacy. The way of injecting drugs will also bring great inconvenience and secondary damage to the body, reducing the risk of damage to patients. dependency. Growth in the pharmaceutical industry, increasing number of patients with chronic diseases, etc. are likely to contribute to the growth of the transdermal drug delivery market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Automatic Transdermal System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PermeGear
BKMD Technology Co.,Ltd.
Shanghai Haoko Scientific Equipment Co., Ltd.
Shanghai Simo Biotechnology Co., Ltd.
Vitrocell
LOGAN
IndiaMART InterMESH Ltd.
United Pharmatek LLC
OPTIMA
Standard Group
Anhui Wanbang Pharmaceutical Technology Co., Ltd.
Segment by Type
Upright
Horizontal
Upright and Horizontal
Segment by Application
Daily Care Products
Biomedicine
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Automatic Transdermal System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The automatic transdermal system is to test the decomposition and diffusion of transdermal drugs or cosmetics under controlled conditions under specified environment and conditions, so as to simulate the in vivo absorption process of the test substance.
Global Automatic Transdermal System market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Automatic Transdermal System market research.
Compared with traditional medication methods, the advantages of transdermal drug delivery systems are the main reason for the rapid development of the market. In addition to effectively avoiding the first-pass effect of the liver, transdermal administration can reduce the irritation of the stomach and intestines caused by oral drugs and reduce the loss of drug efficacy. The way of injecting drugs will also bring great inconvenience and secondary damage to the body, reducing the risk of damage to patients. dependency. Growth in the pharmaceutical industry, increasing number of patients with chronic diseases, etc. are likely to contribute to the growth of the transdermal drug delivery market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Automatic Transdermal System market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PermeGear
BKMD Technology Co.,Ltd.
Shanghai Haoko Scientific Equipment Co., Ltd.
Shanghai Simo Biotechnology Co., Ltd.
Vitrocell
LOGAN
IndiaMART InterMESH Ltd.
United Pharmatek LLC
OPTIMA
Standard Group
Anhui Wanbang Pharmaceutical Technology Co., Ltd.
Segment by Type
Upright
Horizontal
Upright and Horizontal
Segment by Application
Daily Care Products
Biomedicine
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Automatic Transdermal System report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Automatic Transdermal System Market Overview
1.1 Product Overview and Scope of Automatic Transdermal System
1.2 Automatic Transdermal System Segment by Type
1.2.1 Global Automatic Transdermal System Market Value Comparison by Type (2023-2029)
1.2.2 Upright
1.2.3 Horizontal
1.2.4 Upright and Horizontal
1.3 Automatic Transdermal System Segment by Application
1.3.1 Global Automatic Transdermal System Market Value by Application: (2023-2029)
1.3.2 Daily Care Products
1.3.3 Biomedicine
1.4 Global Automatic Transdermal System Market Size Estimates and Forecasts
1.4.1 Global Automatic Transdermal System Revenue 2018-2029
1.4.2 Global Automatic Transdermal System Sales 2018-2029
1.4.3 Global Automatic Transdermal System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Automatic Transdermal System Market Competition by Manufacturers
2.1 Global Automatic Transdermal System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Automatic Transdermal System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Automatic Transdermal System Average Price by Manufacturers (2018-2023)
2.4 Global Automatic Transdermal System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Automatic Transdermal System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Automatic Transdermal System, Product Type & Application
2.7 Automatic Transdermal System Market Competitive Situation and Trends
2.7.1 Automatic Transdermal System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Automatic Transdermal System Players Market Share by Revenue
2.7.3 Global Automatic Transdermal System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Automatic Transdermal System Retrospective Market Scenario by Region
3.1 Global Automatic Transdermal System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Automatic Transdermal System Global Automatic Transdermal System Sales by Region: 2018-2029
3.2.1 Global Automatic Transdermal System Sales by Region: 2018-2023
3.2.2 Global Automatic Transdermal System Sales by Region: 2024-2029
3.3 Global Automatic Transdermal System Global Automatic Transdermal System Revenue by Region: 2018-2029
3.3.1 Global Automatic Transdermal System Revenue by Region: 2018-2023
3.3.2 Global Automatic Transdermal System Revenue by Region: 2024-2029
3.4 North America Automatic Transdermal System Market Facts & Figures by Country
3.4.1 North America Automatic Transdermal System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Automatic Transdermal System Sales by Country (2018-2029)
3.4.3 North America Automatic Transdermal System Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Automatic Transdermal System Market Facts & Figures by Country
3.5.1 Europe Automatic Transdermal System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Automatic Transdermal System Sales by Country (2018-2029)
3.5.3 Europe Automatic Transdermal System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Automatic Transdermal System Market Facts & Figures by Country
3.6.1 Asia Pacific Automatic Transdermal System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Automatic Transdermal System Sales by Country (2018-2029)
3.6.3 Asia Pacific Automatic Transdermal System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Automatic Transdermal System Market Facts & Figures by Country
3.7.1 Latin America Automatic Transdermal System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Automatic Transdermal System Sales by Country (2018-2029)
3.7.3 Latin America Automatic Transdermal System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Automatic Transdermal System Market Facts & Figures by Country
3.8.1 Middle East and Africa Automatic Transdermal System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Automatic Transdermal System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Automatic Transdermal System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Automatic Transdermal System Sales by Type (2018-2029)
4.1.1 Global Automatic Transdermal System Sales by Type (2018-2023)
4.1.2 Global Automatic Transdermal System Sales by Type (2024-2029)
4.1.3 Global Automatic Transdermal System Sales Market Share by Type (2018-2029)
4.2 Global Automatic Transdermal System Revenue by Type (2018-2029)
4.2.1 Global Automatic Transdermal System Revenue by Type (2018-2023)
4.2.2 Global Automatic Transdermal System Revenue by Type (2024-2029)
4.2.3 Global Automatic Transdermal System Revenue Market Share by Type (2018-2029)
4.3 Global Automatic Transdermal System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Automatic Transdermal System Sales by Application (2018-2029)
5.1.1 Global Automatic Transdermal System Sales by Application (2018-2023)
5.1.2 Global Automatic Transdermal System Sales by Application (2024-2029)
5.1.3 Global Automatic Transdermal System Sales Market Share by Application (2018-2029)
5.2 Global Automatic Transdermal System Revenue by Application (2018-2029)
5.2.1 Global Automatic Transdermal System Revenue by Application (2018-2023)
5.2.2 Global Automatic Transdermal System Revenue by Application (2024-2029)
5.2.3 Global Automatic Transdermal System Revenue Market Share by Application (2018-2029)
5.3 Global Automatic Transdermal System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 PermeGear
6.1.1 PermeGear Corporation Information
6.1.2 PermeGear Description and Business Overview
6.1.3 PermeGear Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 PermeGear Automatic Transdermal System Product Portfolio
6.1.5 PermeGear Recent Developments/Updates
6.2 BKMD Technology Co.,Ltd.
6.2.1 BKMD Technology Co.,Ltd. Corporation Information
6.2.2 BKMD Technology Co.,Ltd. Description and Business Overview
6.2.3 BKMD Technology Co.,Ltd. Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BKMD Technology Co.,Ltd. Automatic Transdermal System Product Portfolio
6.2.5 BKMD Technology Co.,Ltd. Recent Developments/Updates
6.3 Shanghai Haoko Scientific Equipment Co., Ltd.
6.3.1 Shanghai Haoko Scientific Equipment Co., Ltd. Corporation Information
6.3.2 Shanghai Haoko Scientific Equipment Co., Ltd. Description and Business Overview
6.3.3 Shanghai Haoko Scientific Equipment Co., Ltd. Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Shanghai Haoko Scientific Equipment Co., Ltd. Automatic Transdermal System Product Portfolio
6.3.5 Shanghai Haoko Scientific Equipment Co., Ltd. Recent Developments/Updates
6.4 Shanghai Simo Biotechnology Co., Ltd.
6.4.1 Shanghai Simo Biotechnology Co., Ltd. Corporation Information
6.4.2 Shanghai Simo Biotechnology Co., Ltd. Description and Business Overview
6.4.3 Shanghai Simo Biotechnology Co., Ltd. Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanghai Simo Biotechnology Co., Ltd. Automatic Transdermal System Product Portfolio
6.4.5 Shanghai Simo Biotechnology Co., Ltd. Recent Developments/Updates
6.5 Vitrocell
6.5.1 Vitrocell Corporation Information
6.5.2 Vitrocell Description and Business Overview
6.5.3 Vitrocell Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Vitrocell Automatic Transdermal System Product Portfolio
6.5.5 Vitrocell Recent Developments/Updates
6.6 LOGAN
6.6.1 LOGAN Corporation Information
6.6.2 LOGAN Description and Business Overview
6.6.3 LOGAN Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 LOGAN Automatic Transdermal System Product Portfolio
6.6.5 LOGAN Recent Developments/Updates
6.7 IndiaMART InterMESH Ltd.
6.6.1 IndiaMART InterMESH Ltd. Corporation Information
6.6.2 IndiaMART InterMESH Ltd. Description and Business Overview
6.6.3 IndiaMART InterMESH Ltd. Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 IndiaMART InterMESH Ltd. Automatic Transdermal System Product Portfolio
6.7.5 IndiaMART InterMESH Ltd. Recent Developments/Updates
6.8 United Pharmatek LLC
6.8.1 United Pharmatek LLC Corporation Information
6.8.2 United Pharmatek LLC Description and Business Overview
6.8.3 United Pharmatek LLC Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 United Pharmatek LLC Automatic Transdermal System Product Portfolio
6.8.5 United Pharmatek LLC Recent Developments/Updates
6.9 OPTIMA
6.9.1 OPTIMA Corporation Information
6.9.2 OPTIMA Description and Business Overview
6.9.3 OPTIMA Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 OPTIMA Automatic Transdermal System Product Portfolio
6.9.5 OPTIMA Recent Developments/Updates
6.10 Standard Group
6.10.1 Standard Group Corporation Information
6.10.2 Standard Group Description and Business Overview
6.10.3 Standard Group Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Standard Group Automatic Transdermal System Product Portfolio
6.10.5 Standard Group Recent Developments/Updates
6.11 Anhui Wanbang Pharmaceutical Technology Co., Ltd.
6.11.1 Anhui Wanbang Pharmaceutical Technology Co., Ltd. Corporation Information
6.11.2 Anhui Wanbang Pharmaceutical Technology Co., Ltd. Automatic Transdermal System Description and Business Overview
6.11.3 Anhui Wanbang Pharmaceutical Technology Co., Ltd. Automatic Transdermal System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Anhui Wanbang Pharmaceutical Technology Co., Ltd. Automatic Transdermal System Product Portfolio
6.11.5 Anhui Wanbang Pharmaceutical Technology Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Automatic Transdermal System Industry Chain Analysis
7.2 Automatic Transdermal System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Automatic Transdermal System Production Mode & Process
7.4 Automatic Transdermal System Sales and Marketing
7.4.1 Automatic Transdermal System Sales Channels
7.4.2 Automatic Transdermal System Distributors
7.5 Automatic Transdermal System Customers
8 Automatic Transdermal System Market Dynamics
8.1 Automatic Transdermal System Industry Trends
8.2 Automatic Transdermal System Market Drivers
8.3 Automatic Transdermal System Market Challenges
8.4 Automatic Transdermal System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
